[1]
|
Mikilineni, R. and Weinstock, M.A. (2001) Epidemiology of Skin Cancer. In: Atlas of Clinical Oncology: Skin Cancer, BC Decker, London, 1-15.
|
[2]
|
Akinci, M., Aslan, S., Morkoc, F. and Cetin, A. (2008) Metastatic Basal Cell Carcinoma. Acta Chirurgica Belgica, 108, 269-272.
|
[3]
|
Lacour, J.P. (2002) Carcinogenesis of Basal Cell Carcinoma: Genetics and Molecular Mechanism. British Journal of Dermatology, 146, 17-19. http://dx.doi.org/10.1046/j.1365-2133.146.s61.5.x
|
[4]
|
Kogerman, P., Krause, D. and Rahnama, F. (2002) Alternative First Exons of PTCH1 Are Differentially Regulated in Vivo and May Confer Different Functions to the PTCH1 Protein. Oncogene, 21, 6007-6016. http://dx.doi.org/10.1038/sj.onc.1205865
|
[5]
|
Kim, M., Park, H.J. and Baek, S. (2002) Mutations of the P53 and PTCH Gene in Basal Cell Carcinoma: UV Mutation Signature and Strand Bias. Journal of Dermatological Science, 29, 1-6.
|
[6]
|
Nouri, K., Christopher, J., Ballard, B.S., Asha R., Patel, B.S. and Brasie, R.A. (2008) Basal Cell Carcinoma. Skin Cancer, The McGraw-Hill Companies.
|
[7]
|
Ting, P.T., Kasper, R. and Arlette, J.P. (2005) Metastatic Basal Cell Carcinoma: Report of Two Cases and Literature Review. Journal of Cutaneous Medicine and Surgery, 9, 10-15.
|
[8]
|
Hoban, P.R., Ramachandran, S. and Strange, R.C. (2002) Environment, Phenotype and Genetics: Risk Factors Associated with BCC of the Skin. Expert Review of Anticancer Therapy, 2, 570-579. http://dx.doi.org/10.1586/14737140.2.5.570
|
[9]
|
Grabski, W.J. and Salasche, S.J. (1998) Positive Surgical Excision Margins of A Basal Cell Carcinoma. Dermatologic Surgery, 24, 921-924. http://dx.doi.org/10.1111/j.1524-4725.1998.tb04276.x
|
[10]
|
Nouri, K., Spencer, J. and Taylor, J. (1999) Does Wound Healing Contribute to the Eradication of Basal Cell Carcinoma Following Curettage and Electrodessication? Dermatologic Surgery, 25, 183. http://dx.doi.org/10.1046/j.1524-4725.1999.08128.x
|
[11]
|
Kaur, S., Thami, G.P. and Kanwar, A.J. (2003) Basal Cell Carcinoma-Treatment with Cryosurgery. Indian Journal of Dermatology, Venereology and Leprology, 69, 188-190.
|
[12]
|
Mendenhall, W.M., Amdur, R.J., Hinerman, R.W., Cognetta, A.B. and Mendenhall, N.P. (2009) Radiotherapy for Cutaneous Squamous and Basal Cell Carcinomas of the Head and Neck. The Laryngoscope, 119, 1994-1999. http://dx.doi.org/10.1002/lary.20608
|
[13]
|
Tierney, E.P. and Hanke, C.W. (2009) Cost Effectiveness of Mohs Micrographic Surgery: Review of the Literature. Journal of Drugs in Dermatology, 8, 914-922.
|
[14]
|
Foley, P. (2005) Clinical Efficacy of Methyl Aminolevulinate Photodynamic Therapy in Basal Cell Carcinoma and Solar Keratosis. Australasian Journal of Dermatology, 46, S8-S10.
|
[15]
|
Padgett, J.K. and Hendrix, J.D. (2001) Cutaneous Malignancies and Their Management. Otolaryngologic Clinics of North America, 34, 523-553. http://dx.doi.org/10.1016/S0030-6665(05)70004-9
|
[16]
|
Kim, K.H., Yavel, R.M. and Gross, V.L. (2004) Intralesional Interferon Alpha-2b in the Treatment of Basal Cell Carcinoma and Squamous Cell Carcinoma: Revisited. Dermatologic Surgery, 30, 116-120.
|
[17]
|
Sharquie, K.E., Al-Nuaimy, A.A. and Al-Shmary, F.A. (2005) New Intralesional Therapy for Basal Cell Carcinoma by 2% Zinc Sulphate Solution. Saudi Medical Journal, 26, 359-361.
|
[18]
|
Love, W.E., Bernhard, J.D. and Bordeaux, J.S. (2009) Topical Imiquimod or Fluorouracil Therapy for Basal and Squamous Cell Carcinoma: A Systematic Review. Archives of Dermatology, 145, 1431-1438. http://dx.doi.org/10.1001/archdermatol.2009.291
|
[19]
|
Bianchi, L., Orlandi, A., Campione, E., Angeloni, C., Costanzo, A. and Spagnoli, L.G. (2004) Topical Treatment of Basal Cell Carcinoma with Tazarotene: A Clinicopathological Study on a Large Series of Cases. British Journal of Dermatology, 151, 148-156. http://dx.doi.org/10.1111/j.1365-2133.2004.06044.x
|
[20]
|
United State Pharmacopeia Committees (Eds.) (2004) Podophyllin. In: United State Pharmacopeia Committees, Eds., Drug Information for the Health Care Professional, 24th Edition, Rev. US Convention Inc., Thomason Micromedex, 2341-2348.
|
[21]
|
Podophyllum (Topical). Drugs.com. Know More Be Sure. Update 3 August 2000. http://www.drugs.com/mmx/podocon-25.html
|
[22]
|
Katzung, B.G. (1992) Basic and Clinical Pharmacology. 5th Edition, Appleton and Lange, Norwalk, 884.
|
[23]
|
Martin, E.C., Christy, L., Cowan, M.C., Marshal, S.W., Dawson, A.H., Seifert, S.A., Schon, W.S., Yip, L., Keyes, D.C., Hurlbut, K.M. and Erdman Arm Dart, R.C. (Eds). (2004) Medical Toxicology. 3rd Edition, Chap. 255, Walters Kluwer Company, Philadelphia, 1690-1691.
|
[24]
|
Lin, M.C., Cheng, H.W., Tsai, Y.C., Liao, P.L. and Kang, J.J. (2009) Podophyllin Induced Genotoxicity in Vitro and in Vivo through ROS Production. Drug and Chemical Toxicology, 32, 68-76. http://dx.doi.org/10.1080/01480540802433757
|
[25]
|
Rahman, A.U., Ashraf, M., Choudhary, M.I., Rehman, H.U. and Kazmi, M.H. (1995) Antifungal Aryltetralin Lignans from Leaves of Podophyllum hexandrum. Phytochemistry, 40, 427-431. http://dx.doi.org/10.1016/0031-9422(95)00195-D
|
[26]
|
Beutner, K.R. and Ferenczy, A. (1997) Therapeutic Approaches to Genital Warts. The American Journal of Medicine, 102, 28-37. http://dx.doi.org/10.1016/S0002-9343(97)00181-2
|
[27]
|
Moore, M.M. and Strober, B.E. (2008) Topical and Intralesional Cytotoxic Agent. In: Wolff, K., Goldsmith, L.A., Katz, S.I., Gilchrest, B.A., Paller, A.S. and Leffell, D.J., Eds., Fitzpatrick’s Dermatology in General Medicine, 7th Edition, Chap. 220, McGraw-Hill-Company, New York, 2124.
|
[28]
|
Habif, T.P. (2004) Sexually Transmitted Viral Infection. In: Habif, T.P., Ed., Clinical Dermatology, 4th Edition, Chap. 11, Mosby Inc., Toronto, 336-342.
|
[29]
|
Huber, A., Huber, J.D. and Skinner, R.B. (2004) Topical Imiquimod Treatment for Nodular Basal Cell Carcinomas: An Open-Label Series. Dermatologic Surgery, 30, 429-430. http://dx.doi.org/10.1097/00042728-200403000-00023
|
[30]
|
Vidal, D., Matias-Guiu, X. and Alomar, A. (2004) Open Study of the Efficacy and Mechanism of Action of Topical Imiquimod in Basal Cell Carcinoma. Clinical and Experimental Dermatology, 29, 518-525. http://dx.doi.org/10.1111/j.1365-2230.2004.01601.x
|
[31]
|
Efudex (Fluorouracil) Topical Solution and Cream (Product Pamphlet). ICN Pharmaceuticals, Inc., Costa Mesa, 2000.
|
[32]
|
Berman, B., Sullivan, T. and De Araujo, T. (2003) Expression of Fas-Receptor on Basal Cell Carcinomas after Treatment with Imiquimod 5% Cream or Vehicle. British Journal of Dermatology, 149, 59-61. http://dx.doi.org/10.1046/j.0366-077X.2003.05634.x
|
[33]
|
Lawrence, C.M. (1999) Mohs Micrographic Surgery for Basal Cell Carcinoma. Clinical and Experimental Dermatology, 24, 130-133. http://dx.doi.org/10.1046/j.1365-2230.1999.00433.x
|
[34]
|
Reymann, F. (1979) Treatment of Basal Cell Carcinoma of the Skin with 5-Fluorouracil Ointment. Dermatologica, 158, 368-372. http://dx.doi.org/10.1159/000250782
|